21-42376583-C-A

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM1PM2PM5PP2PP3_ModeratePP5

The NM_001256317.3(TMPRSS3):​c.1149G>T​(p.Met383Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,572 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M383K) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

TMPRSS3
NM_001256317.3 missense

Scores

6
11
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:2

Conservation

PhyloP100: 7.24

Publications

1 publications found
Variant links:
Genes affected
TMPRSS3 (HGNC:11877): (transmembrane serine protease 3) This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a serine protease domain, a transmembrane domain, an LDL receptor-like domain, and a scavenger receptor cysteine-rich domain. Serine proteases are known to be involved in a variety of biological processes, whose malfunction often leads to human diseases and disorders. This gene was identified by its association with both congenital and childhood onset autosomal recessive deafness. This gene is expressed in fetal cochlea and many other tissues, and is thought to be involved in the development and maintenance of the inner ear or the contents of the perilymph and endolymph. This gene was also identified as a tumor-associated gene that is overexpressed in ovarian tumors. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jan 2012]
TMPRSS3 Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive nonsyndromic hearing loss 8
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 4 uncertain in NM_001256317.3
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr21-42376584-A-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 873474.
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 41 curated pathogenic missense variants (we use a threshold of 10). The gene has 12 curated benign missense variants. Trascript score misZ: 0.22926 (below the threshold of 3.09). GenCC associations: The gene is linked to hearing loss, autosomal recessive, autosomal recessive nonsyndromic hearing loss 8, nonsyndromic genetic hearing loss.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.925
PP5
Variant 21-42376583-C-A is Pathogenic according to our data. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482. Variant chr21-42376583-C-A is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 165482.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMPRSS3NM_001256317.3 linkc.1149G>T p.Met383Ile missense_variant Exon 11 of 13 ENST00000644384.2 NP_001243246.1 P57727-5
TMPRSS3NM_024022.4 linkc.1152G>T p.Met384Ile missense_variant Exon 11 of 13 NP_076927.1 P57727-1
TMPRSS3NM_032404.3 linkc.771G>T p.Met257Ile missense_variant Exon 8 of 10 NP_115780.1 P57727-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMPRSS3ENST00000644384.2 linkc.1149G>T p.Met383Ile missense_variant Exon 11 of 13 NM_001256317.3 ENSP00000494414.1 P57727-5

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461572
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
727074
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53150
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5748
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1111992
Other (OTH)
AF:
0.00
AC:
0
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Pathogenic:1
Dec 29, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 384 of the TMPRSS3 protein (p.Met384Ile). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TMPRSS3-related conditions. ClinVar contains an entry for this variant (Variation ID: 165482). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TMPRSS3 protein function with a positive predictive value of 95%. This variant disrupts the p.Met384 amino acid residue in TMPRSS3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 3285355, 36633841; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

not specified Uncertain:1
May 15, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The Met384Ile variant in TMPRSS3 has not been reported in individuals with heari ng loss or in large population studies. Computational analyses (biochemical amin o acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) do not provide strong support for or against an impact to the protein. In summary, additional d ata is needed to determine the clinical significance of this variant. -

Autosomal recessive nonsyndromic hearing loss 8 Uncertain:1
Mar 09, 2015
Division of Human Genetics, Children's Hospital of Philadelphia
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:research

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.96
BayesDel_addAF
Pathogenic
0.39
D
BayesDel_noAF
Pathogenic
0.33
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.73
.;D;D;.
Eigen
Uncertain
0.62
Eigen_PC
Uncertain
0.61
FATHMM_MKL
Benign
0.29
N
LIST_S2
Uncertain
0.88
D;.;D;D
M_CAP
Pathogenic
0.57
D
MetaRNN
Pathogenic
0.92
D;D;D;D
MetaSVM
Uncertain
0.50
D
MutationAssessor
Uncertain
2.3
.;M;M;.
PhyloP100
7.2
PrimateAI
Uncertain
0.61
T
PROVEAN
Uncertain
-3.8
.;.;D;D
REVEL
Pathogenic
0.81
Sift
Uncertain
0.0030
.;.;D;D
Sift4G
Uncertain
0.0090
.;.;D;D
Polyphen
0.48
P;D;D;D
Vest4
0.83, 0.83
MutPred
0.81
.;Loss of sheet (P = 0.1158);Loss of sheet (P = 0.1158);.;
MVP
0.84
MPC
0.55
ClinPred
0.99
D
GERP RS
4.9
Varity_R
0.73
gMVP
0.92
Mutation Taster
=19/81
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs727503492; hg19: chr21-43796692; API